Does EDOXABAN Cause Haemoglobin decreased? 119 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 119 reports of Haemoglobin decreased have been filed in association with EDOXABAN (SAVAYSA). This represents 1.4% of all adverse event reports for EDOXABAN.
119
Reports of Haemoglobin decreased with EDOXABAN
1.4%
of all EDOXABAN reports
7
Deaths
89
Hospitalizations
How Dangerous Is Haemoglobin decreased From EDOXABAN?
Of the 119 reports, 7 (5.9%) resulted in death, 89 (74.8%) required hospitalization, and 12 (10.1%) were considered life-threatening.
Is Haemoglobin decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EDOXABAN. However, 119 reports have been filed with the FAERS database.
What Other Side Effects Does EDOXABAN Cause?
Anaemia (663)
Cerebral infarction (419)
Gastrointestinal haemorrhage (378)
Renal impairment (359)
Cerebrovascular accident (337)
Dyspnoea (331)
General physical health deterioration (315)
Haematuria (312)
Fall (298)
Cardiac failure (272)
What Other Drugs Cause Haemoglobin decreased?
LENALIDOMIDE (4,031)
RUXOLITINIB (3,297)
ECULIZUMAB (3,028)
ADALIMUMAB (2,459)
CLOZAPINE (2,396)
RITUXIMAB (1,803)
APIXABAN (1,779)
NIRAPARIB (1,759)
METHOTREXATE (1,754)
RIBAVIRIN (1,753)
Which EDOXABAN Alternatives Have Lower Haemoglobin decreased Risk?
EDOXABAN vs EDOXABAN TOSILATE
EDOXABAN vs EFALIZUMAB
EDOXABAN vs EFANESOCTOCOG ALFA
EDOXABAN vs EFAVIRENZ
EDOXABAN vs EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL